Advertisement
YOU ARE HERE: LAT HomeCollectionsLederle Laboratories
IN THE NEWS

Lederle Laboratories

FEATURED ARTICLES
ARTICLES BY DATE
NEWS
August 8, 1991 | SHARI ROAN
A new pertussis vaccine that could be given as a booster to children at 18 months and again at school age may be available later this year, according to the vaccine's manufacturer. The alternative vaccine would be significant because of the controversy that has dogged the current DPT shot.
Advertisement
BUSINESS
March 22, 1987
International Pharmaceutical Products Inc., a Costa Mesa-based pharmaceutical company, said it has received Food and Drug Administration approval to market Abitrexate, the brand name of a cancer-treatment drug, for an Israeli manufacturer. The product is the generic equivalent of methotrexate, a drug originally developed by New York-based Lederle Laboratories in 1982. International Pharmaceutical Products has an exclusive marketing agreement with ABIC Ltd.
NEWS
August 8, 1991 | SHARI ROAN
A new pertussis vaccine that could be given as a booster to children at 18 months and again at school age may be available later this year, according to the vaccine's manufacturer. The alternative vaccine would be significant because of the controversy that has dogged the current DPT shot.
BUSINESS
July 2, 1999
Francis R. Cano was elected to the board of directors of Biomerica Inc. in Newport Beach. Cano helped develop a $500-million vaccine business at Lederle Laboratories, a division of American Cyanamid Co., and was president and chief operating officer of Aviron in Mountain View, a biotechnology company.
BUSINESS
December 16, 1992 | From Times Staff and Wire Reports
The New York Stock Exchange said it has suspended trading in Trans World Airline's $2.25 preferred stock on the expectation that shareholders will receive nothing in the airline's bankruptcy reorganization. . . . American Cyanamid Co. and Immunex Corp. announced that they have agreed to create a new bio-pharmaceutical company, merging Cyanamid's North American Lederle Laboratories oncology business with Immunex.
BUSINESS
February 25, 1993 | Anne Michaud / Times staff writer
First Aid for Ad Agency: Health care is the industry that's been good lately to ad agency Forsythe Marcelli Johnson. The company, based in Newport Beach, said it has hired five people in response to a 33% increase in billings during 1992. Among the newcomers is an account supervisor, John Sullivan, hired to work with Northern California medical-device makers, the company said. He had spent 15 years working in sales and marketing with Lederle Laboratories.
BUSINESS
December 17, 1988 | Leslie Berkman, Times staff writer
Techniclone International, a biotechnology research and development company, has moved from its Santa Ana headquarters to a new 14,000-square-foot factory in Tustin that has been specially designed for producing monoclonal antibodies, the basic components of high-tech biological drugs. Techniclone has built the facility to gear up for production of drugs it hopes will be approved for sale by the U.S. Food and Drug Administration to treat various forms of cancer.
BUSINESS
March 22, 1987
International Pharmaceutical Products Inc., a Costa Mesa-based pharmaceutical company, said it has received Food and Drug Administration approval to market Abitrexate, the brand name of a cancer-treatment drug, for an Israeli manufacturer. The product is the generic equivalent of methotrexate, a drug originally developed by New York-based Lederle Laboratories in 1982. International Pharmaceutical Products has an exclusive marketing agreement with ABIC Ltd.
BUSINESS
June 21, 1989 | From Times wire services
A widely used drug for treating epilepsy and manic depression caused mental and physical defects in infants whose mothers took the drug during pregnancy, a new study said today. The drug, Tegretol, delayed the mental development of 20% of children exposed to the drug prenatally, increasing the risk that these children may become retarded, according to the study in the latest issue of the New England Journal of Medicine. Tegretol, the brand name for the chemical carbamazepine, is made by the Swiss firm Ciba-Geigy AG, whose U.S. headquarters are in Summit, N.J. Carbamazepine is also made by Lederle Laboratories of American Cyanamid Co. in Wayne, N.J. Ciba-Geigy responded in a statement that the study is flawed and does not "provide conclusive information on the use of Tegretol in pregnant women."
BUSINESS
July 22, 1986 | HENRY RIVERO
Techniclone International Corp., a Santa Ana bio-engineering company, has confirmed the previously announced purchase by American Cyanamid Inc. of a 4% interest in Techniclone, or about 21.2 million shares. American Cyanamid of Wayne, N.J.
Los Angeles Times Articles
|